VRCA – verrica pharmaceuticals inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Days Volatility
Open
Prior Close

YTD

1 Day

VRCA

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/21

07:30 am

vrca

Verrica Announces Pricing of $42.0 Million Public Offering

High Report

Verrica Announces Pricing of $42.0 Million Public Offering

Report

11/20

04:15 pm

vrca

Verrica Announces Proposed Public Offering [Yahoo! Finance]

High Report

Verrica Announces Proposed Public Offering [Yahoo! Finance]

Report

11/20

04:05 pm

vrca

Verrica Announces Proposed Public Offering

High Report

Verrica Announces Proposed Public Offering

Report

11/6

07:32 am

vrca

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.

Medium Report

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at HC Wainwright from a "buy" rating to a "neutral" rating.

Report

11/5

02:32 pm

vrca

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.

Medium Report

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) had its "hold" rating re-affirmed by analysts at Needham & Company LLC.

Report

11/5

07:00 am

vrca

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.

High Report

Verrica Pharmaceuticals Inc. (NASDAQ: VRCA) was downgraded by analysts at Royal Bank of Canada from an "outperform" rating to a "sector perform" rating.

Report

11/4

04:05 pm

vrca

Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition

High Report

Verrica Pharmaceuticals Reports Third Quarter 2024 Financial Results and Announces Leadership Transition

Report

10/30

10:00 am

vrca

Verrica Pharmaceuticals Inc. Investor Alert (NASDAQ: VRCA): Schubert Jonckheer & Kolbe LLP Investigating Potential Shareholder Claims Against the Company's Officers and Directors for Possible False Statements

Low Report

Report

Date

Time

Symbol

Company Name

Action

%Chg

8/14/2024

07:45 am

vrca

verrica pharmaceuticals inc.

BEAT Report

-51.4%

verrica pharmaceuticals inc.

Report

5/13/2024

07:30 am

vrca

verrica pharmaceuticals inc.

BEAT Report

23.0%

verrica pharmaceuticals inc.

Report

2/29/2024

07:30 am

vrca

verrica pharmaceuticals inc.

MISS Report

-8.3%

verrica pharmaceuticals inc.

Report

Date

Time

Action

From

Firm

Impact

%Chg

11/6

07:32 am

Downgrades

Buy

Neutral

HC Wainwright

Medium

Report

-6.9%

Report

11/5

02:32 pm

Reiterates

Hold

Needham & Company LLC

Medium

Report

-3.8%

Report

11/5

02:21 pm

Reiterates

Hold

Needham

Medium

Report

-4.9%

Report

11/5

02:21 pm

Reiterates

Hold

Needham

Medium

Report

-4.9%

Report

11/5

10:48 am

Downgrades

Outperform

Sector Perform

RBC Capital

Medium

Report

-7.6%

Report

11/5

10:48 am

Downgrades

Outperform

Sector Perform

RBC Capital

Medium

Report

-7.6%

Report

11/5

07:00 am

Downgrades

Outperform

Sector Perform

Royal Bank of Canada

High

Report

-16.9%

Report

11/5

07:00 am

Downgrades

Outperform

Sector Perform

Royal Bank of Canada

High

Report

-16.9%

Report

Date

Time

Symbol

Headline

Impact

11/20

05:09 pm

vrca

Form 8-K Verrica Pharmaceuticals For: Nov 20

High Report

Form 8-K Verrica Pharmaceuticals For: Nov 20

Report

11/20

05:06 pm

vrca

Form 424B5 Verrica Pharmaceuticals

High Report

Form 424B5 Verrica Pharmaceuticals

Report

11/14

09:33 am

vrca

Form SC 13G/A Verrica Pharmaceuticals Filed by: Avoro Capital Advisors LLC

Low Report

Form SC 13G/A Verrica Pharmaceuticals Filed by: Avoro Capital Advisors LLC

Report

11/6

09:05 pm

vrca

Form 4 Verrica Pharmaceuticals For: Nov 06 Filed by: Kirby John J.

Medium Report

Form 4 Verrica Pharmaceuticals For: Nov 06 Filed by: Kirby John J.

Report

11/6

09:04 pm

vrca

Form 3 Verrica Pharmaceuticals For: Nov 05 Filed by: Kirby John J.

Medium Report

Form 3 Verrica Pharmaceuticals For: Nov 05 Filed by: Kirby John J.

Report

11/6

09:03 pm

vrca

Form 4 Verrica Pharmaceuticals For: Nov 06 Filed by: Rieger Jayson

Medium Report

Form 4 Verrica Pharmaceuticals For: Nov 06 Filed by: Rieger Jayson

Report

11/6

09:00 pm

vrca

Form 3 Verrica Pharmaceuticals For: Nov 05 Filed by: Rieger Jayson

Medium Report

Form 3 Verrica Pharmaceuticals For: Nov 05 Filed by: Rieger Jayson

Report

11/6

05:12 pm

vrca

Form S-8 Verrica Pharmaceuticals

Medium Report

Form S-8 Verrica Pharmaceuticals

Report

Stock Stats

News Stats
All News
News Wires
Media Monitoring
SEC Edgar Filings
Upgrades
Downgrades
Initiated
Reiterated
Last Earnings
Last Earnings EPS
Next Earnings

Order Stats
Sub-Penny

Odd lot

Avg. bid-ask spread

Avg. bid-ask size

Shares at ask/bid

Off exchange

Main News & Impact Reports

Don’t Miss Out On The Next BIG Stock Move

Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below:

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.